Cassier, Philippe A
Castets, Marie
Belhabri, Amine
Vey, Norbert
Article History
Received: 19 December 2016
Revised: 12 June 2017
Accepted: 7 July 2017
First Online: 24 August 2017
Competing interests
: PAC has received honorarium and/or research funding from Amgen, Astra-Zeneca, Bayer, Blueprint Medicines, Bristol Myers Squib, Celgene, Lilly, Merck Serono, Merck Sharp Dohme, Novartis, Roche/Genentech. AB has received honorarium and/or institutional research funding from Celgene, Novartis, Bristol Myers Squib, Pfizer. NV has received honorarium from Amgen, Celgene, Novartis, Servier. MC declares no relevant conflict of interest.